Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1750 of 2873 entries
View as:

Radical Trachelectomy for Women With Early Stage Cervical Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00813007 Org: User:
Start: 12/16/08 End: 12/31/20 Due: 12/31/21

Gemcitabine Pharmacokinetics After Preoperative Chemoradiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT01938716 Org: User:
Start: 03/31/12 End: 06/03/19 Due: 06/03/20

Neoadjuvant Listeria or Daratumumab in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT03035357 Org: User:
Start: 03/01/17 End: 03/01/19 Due: 03/01/20

A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC

Phase: N/A Priority: Normal
NCT ID: NCT06826768 Org: User:
Start: 05/01/25 End: 05/01/29 Due: 05/01/30

Evaluation of the Addition of Herceptin to Standard Chemotherapy in the Neoadjuvant Setting for Operable Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00038402 Org: User:
Start: 04/30/01 End: 07/31/11 Due: 07/31/12

Carotid Artery Disease in Childhood Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT00591539 Org: User:
Start: 12/31/07 End: 08/31/10 Due: 08/31/11

Yoga Program for Lung Cancer Patients and Caregivers

Phase: N/A Priority: Normal
NCT ID: NCT02196844 Org: User:
Start: 09/29/14 End: 02/02/23 Due: 02/02/24

Pembrolizumab and PEGPH20 in Treating Patients With Metastatic Pancreatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04058964 Org: User:
Start: 02/01/20 End: 10/31/22 Due: 10/31/23

Motion Correction of Positron Emission Tomography (PET) Data Using Amplitude Gating

Phase: N/A Priority: Normal
NCT ID: NCT00843219 Org: User:
Start: 03/31/09 End: 12/31/11 Due: 12/31/12

Ontak (Denileukin Diftitox) in Patients With Systemic Mastocytosis (SM)

Phase: N/A Priority: Normal
NCT ID: NCT00493129 Org: User:
Start: 07/31/04 End: 08/31/07 Due: 08/31/08

Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction

Phase: N/A Priority: Normal
NCT ID: NCT01310075 Org: User:
Start: 02/28/11 End: 11/08/17 Due: 11/08/18

Modified T Cells, Chemotherapy, and Aldesleukin With or Without LV305 and CMB305 in Treating Participants With Advanced or Recurrent Sarcoma

Phase: N/A Priority: Normal
NCT ID: NCT03450122 Org: User:
Start: 09/13/18 End: 12/06/22 Due: 12/06/23

Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism

Phase: N/A Priority: Normal
NCT ID: NCT03052075 Org: User:
Start: 09/03/14 End: 09/30/20 Due: 09/30/21

Radiation Therapy in Treating Patients With Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function

Phase: N/A Priority: Normal
NCT ID: NCT02626312 Org: User:
Start: 02/15/16 End: 04/28/26 Due: 04/28/27

Ibrutinib in Treating Participants With Untreated High Risk Smoldering Mantle Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03282396 Org: User:
Start: 06/08/20 End: 02/28/26 Due: 02/28/27

Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials

Phase: N/A Priority: Normal
NCT ID: NCT00500513 Org: User:
Start: 04/30/04 End: 12/31/11 Due: 12/31/12

Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00392769 Org: User:
Start: 10/31/06 End: 12/31/10 Due: 12/31/11

In Vivo Dosimetry During Prostate Cancer Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01307852 Org: User:
Start: 11/30/11 End: 09/30/15 Due: 09/30/16

Dalteparin in Preventing DVT in Participants With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00525057 Org: User:
Start: 07/07/06 End: 06/19/20 Due: 06/19/21

A Phase Ib Study of Rezatapopt in Combination With Azacitidine in Patients With TP53Y220C Mutant Myeloid Malignancies (Acute Myeloid Leukemia or Myelodysplastic Syndrome)

Phase: N/A Priority: Normal
NCT ID: NCT06616636 Org: User:
Start: 01/30/25 End: 08/27/29 Due: 08/27/30

ALLG AMLM26 INTERCEPT (Investigating Novel Therapy to Target Early Relapse and Clonal Evolution as Pre-emptive Therapy in AML): A Multi-arm, Precision-based, Recursive, Platform Trial

Phase: N/A Priority: Normal
NCT ID: NCT06664879 Org: User:
Start: 12/30/24 End: 07/31/28 Due: 07/31/29

Cisplatin, Temozolomide, Abraxane, With Interleukin-2 and Interferon for Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT00970996 Org: User:
Start: 09/30/09 End: 12/31/12 Due: 12/31/13

Manual Therapy in Treating Fibrosis-Related Late Effect Dysphagia in Head and Neck Cancer Survivors

Phase: N/A Priority: Normal
NCT ID: NCT03612531 Org: User:
Start: 08/06/18 End: 12/31/25 Due: 12/31/26

Randomized Double Cord Blood Transplant Study

Phase: N/A Priority: Normal
NCT ID: NCT00067002 Org: User:
Start: 04/30/03 End: 07/31/16 Due: 07/31/17

Iressa/Docetaxel in Non-Small-Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00048087 Org: User:
Start: 08/31/02 End: 07/31/03 Due: 07/31/04